HIV Infected Individuals
5
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
4 treatments under study, led by Zoledronic Acid 5 Mgbag 100 Ml Inj
Research Leaders
10 sponsors active, led by Vanderbilt University Medical Center
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
20%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (5)
The Efficacy and Safety Study of CAR-T Cells for Functional Cure in HIV-1/AIDS Patients
Zoledronic Acid for the Prevention of TDF-sparing ART-induced Bone Mass Density Loss in Treatment-naive HIV Positive Individuals
Piloting Eye Movement Desensitization and Reprocessing (EMDR) Therapy in People Living With HIV and Trauma
Analysis of the Persistence, Reservoir and HIV Latency
The Influence of Psychological Interventions Upon Disease Progression in HIV-infected Patients Receiving no Medication
Research Network
Common Treatments
- Zoledronic Acid 5 Mgbag 100 Ml Inj1
- Hivcart1
- Hypnosis1
- Emdr Therapy Protocol1
Active Sponsors
- Vanderbilt University Medical Center1
- Imperial College London1
- Hadassah Medical Organization1
- University Hospital, Strasbourg, France1
- Tsinghua University1
Top Investigators
Imperial College London
Rambam Health Care Campus
Hadassah University Medical center
Sheba Medical Center
Imperial College London
Related Conditions
- Hiv1
- Informed Consent1
- Osteopenia1